Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 09 04:00PM ET
0.7152
Dollar change
+0.0202
Percentage change
2.91
%
Index- P/E- EPS (ttm)-1.50 Insider Own17.47% Shs Outstand23.87M Perf Week-8.97%
Market Cap16.81M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float19.70M Perf Month-49.99%
Income-27.76M PEG- EPS next Q- Inst Own7.34% Short Float1.25% Perf Quarter-74.09%
Sales12.75M P/S1.32 EPS this Y- Inst Trans2.64% Short Ratio1.79 Perf Half Y-84.11%
Book/sh2.00 P/B0.36 EPS next Y- ROA-30.25% Short Interest0.25M Perf Year-85.95%
Cash/sh0.05 P/C15.28 EPS next 5Y- ROE-58.71% 52W Range0.66 - 7.48 Perf YTD-84.18%
Dividend Est.- P/FCF- EPS past 5Y-47.90% ROI-46.12% 52W High-90.44% Beta-0.32
Dividend TTM- Quick Ratio1.33 Sales past 5Y91.63% Gross Margin-32.38% 52W Low8.36% ATR (14)0.10
Dividend Ex-DateMay 24, 2022 Current Ratio1.47 EPS Y/Y TTM-141.87% Oper. Margin-277.69% RSI (14)22.25 Volatility8.84% 9.18%
Employees113 Debt/Eq0.78 Sales Y/Y TTM-79.66% Profit Margin-217.64% Recom1.00 Target Price16.00
Option/ShortYes / Yes LT Debt/Eq0.58 EPS Q/Q-15.34% Payout- Rel Volume0.92 Prev Close0.69
Sales Surprise11.56% EPS Surprise-12.90% Sales Q/Q-62.39% EarningsNov 13 BMO Avg Volume137.60K Price0.72
SMA20-4.83% SMA50-56.49% SMA200-79.98% Trades Volume126,285 Change2.91%
Date Action Analyst Rating Change Price Target Change
Dec-20-21Initiated H.C. Wainwright Buy $12
Oct-13-21Downgrade Dawson James Buy → Neutral
Jan-20-21Initiated Dawson James Buy $25
Nov-19-24 08:00AM
Nov-18-24 08:01PM
08:00AM
Nov-13-24 09:15AM
08:00AM
04:05PM Loading…
Nov-12-24 04:05PM
Nov-11-24 09:52AM
Nov-07-24 11:37PM
04:05PM
Nov-04-24 08:00AM
Oct-22-24 08:00AM
Oct-17-24 08:00AM
Sep-11-24 01:00PM
Aug-27-24 08:00AM
Aug-22-24 08:00AM
11:10AM Loading…
Aug-19-24 11:10AM
Aug-14-24 08:00AM
Aug-13-24 08:00AM
Aug-07-24 08:00AM
Jul-11-24 08:00AM
May-16-24 08:00AM
May-10-24 04:19PM
May-09-24 03:40PM
08:00AM
May-02-24 10:01AM
08:00AM
Apr-29-24 09:00AM
Apr-25-24 08:00AM
Apr-23-24 09:00AM
Apr-16-24 08:00AM
08:00AM Loading…
Apr-10-24 08:00AM
Apr-01-24 09:00PM
Mar-18-24 09:20AM
09:08AM
Mar-15-24 12:53PM
08:00AM
Mar-08-24 08:00AM
Feb-21-24 08:00AM
Feb-20-24 08:00AM
Feb-14-24 08:00AM
Feb-08-24 08:00AM
Jan-30-24 08:00AM
Jan-23-24 08:00AM
Jan-04-24 08:00AM
Nov-10-23 01:50PM
Nov-09-23 09:25AM
08:00AM
Nov-02-23 08:00AM
Oct-17-23 08:00AM
Oct-12-23 08:25AM
08:00AM
Aug-10-23 10:40AM
09:30AM
08:00AM
Aug-03-23 08:00AM
Aug-02-23 08:00AM
Jun-29-23 08:00AM
Jun-22-23 08:30AM
Jun-09-23 08:00AM
Jun-07-23 08:00AM
Jun-01-23 08:30AM
May-11-23 09:35AM
08:00AM
May-08-23 08:30AM
May-04-23 08:30AM
May-03-23 08:30AM
03:43AM
May-01-23 08:00AM
01:54AM
Apr-28-23 08:30AM
Apr-27-23 06:36PM
08:03AM
08:00AM
Apr-25-23 08:30AM
Apr-24-23 09:00AM
Apr-18-23 08:00AM
Apr-10-23 03:20AM
Mar-31-23 06:37AM
Mar-30-23 08:27AM
Mar-28-23 09:35AM
08:00AM
Mar-21-23 08:00AM
Mar-15-23 08:00AM
Mar-13-23 08:00AM
Mar-10-23 06:52PM
Mar-07-23 08:00AM
Mar-01-23 08:00AM
Feb-22-23 08:00AM
Feb-16-23 08:00AM
Feb-15-23 08:00AM
Feb-06-23 08:00AM
Jan-19-23 05:55AM
Jan-05-23 08:00AM
Dec-19-22 08:30AM
Dec-15-22 09:12AM
Dec-05-22 08:30AM
Nov-30-22 08:00AM
Nov-12-22 07:43AM
Nov-10-22 09:35AM
08:00AM
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.